- Home
- CCIX vs FTRE Comparison
CCIX vs FTRE Comparison
Compare CCIX & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCIX
- FTRE
- Stock Information
- Founded
- CCIX 2023
- FTRE 1996
- Country
- CCIX United States
- FTRE United States
- Employees
- CCIX N/A
- FTRE N/A
- Industry
- CCIX
- FTRE Medical Specialities
- Sector
- CCIX
- FTRE Health Care
- Exchange
- CCIX Nasdaq
- FTRE Nasdaq
- Market Cap
- CCIX 406.6M
- FTRE 469.0M
- IPO Year
- CCIX 2024
- FTRE N/A
- Fundamental
- Price
- CCIX $10.57
- FTRE $5.32
- Analyst Decision
- CCIX
- FTRE Hold
- Analyst Count
- CCIX 0
- FTRE 11
- Target Price
- CCIX N/A
- FTRE $17.10
- AVG Volume (30 Days)
- CCIX 391.7K
- FTRE 2.7M
- Earning Date
- CCIX 01-01-0001
- FTRE 08-11-2025
- Dividend Yield
- CCIX N/A
- FTRE N/A
- EPS Growth
- CCIX N/A
- FTRE N/A
- EPS
- CCIX 0.34
- FTRE N/A
- Revenue
- CCIX N/A
- FTRE $2,685,600,000.00
- Revenue This Year
- CCIX N/A
- FTRE N/A
- Revenue Next Year
- CCIX N/A
- FTRE $1.36
- P/E Ratio
- CCIX $31.04
- FTRE N/A
- Revenue Growth
- CCIX N/A
- FTRE N/A
- 52 Week Low
- CCIX $10.00
- FTRE $3.97
- 52 Week High
- CCIX $11.66
- FTRE $28.41
- Technical
- Relative Strength Index (RSI)
- CCIX N/A
- FTRE 49.95
- Support Level
- CCIX N/A
- FTRE $3.97
- Resistance Level
- CCIX N/A
- FTRE $6.56
- Average True Range (ATR)
- CCIX 0.00
- FTRE 0.49
- MACD
- CCIX 0.00
- FTRE 0.10
- Stochastic Oscillator
- CCIX 0.00
- FTRE 52.12
About CCIX Churchill Capital Corp IX Ordinary Shares
Churchill Capital Corp IX is a blank check company.
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.